Neoadjuvant docetaxel, vinorelbine and trastuzumab prior to surgery and adjuvant therapy is active in patients with HER-2 breast cancer

By  

Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Controversies in breast cancer: adjuvant and neoadjuvant therapy

By Montemurro Filippo   Redana Stefania   Valabrega Giorgio   Aglietta Massimo  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1055-1072

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel: As Adjuvant or Neoadjuvant Therapy in Early Breast Cancer

By Dene Simpson   Greg L. Plosker  

Drugs, Vol. 64, Iss. 16, 2004-01 ,pp. : 1839-1847

Adis International

Access to resources Recommend Favorite

Docetaxel as Single-Agent Treatment in Elderly Patients with Advanced Breast Cancer

By Lorenzo I.   Constenla M.   Palacios P.   García-Arroyo F.R.   Fernández I.   Campos B.   Salgado L.   Carrete N.  

Clinical Drug Investigation, Vol. 25, Iss. 4, 2005-01 ,pp. : 249-256

Adis International

Access to resources Recommend Favorite

Paclitaxel and docetaxel in the treatment of breast cancer

By Saloustros Emmanouel   Mavroudis Dimitris   Georgoulias Vassilis  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2603-2616

Informa Healthcare

Access to resources Recommend Favorite